- 2015
- Press releases - 26.10.2015
Obesity: surgery corrects diabetes even before weight loss occurs
Each year, obesity kills 2.8 million people worldwide. When confronting morbid overweight—and its direct consequence, type 2 diabetes—surgery is used as a last resort. Strangely, in patients who have had such an operation, the diabetes disappears before and independently of weight loss. Inserm researchers, with the help of physicians from Bichat Hospital, AP-HP, have shown that the surgically reconfigured intestine might be at the root of this improved glycaemic control. This study is published in Gastroenterology.
- Press releases - 22.10.2015
Radioactive sources discovered at the University of Bordeaux
Inserm is paying close attention to the level 2 incident, declared on 21 October 2015 by the French Nuclear Safety Authority (ASN), which occurred in a joint Inserm/University of Bordeaux laboratory.
- Press releases - 21.10.2015
Fresh insight into the causes of infant and perinatal mortality in the Seine-Saint-Denis district
In 2012, the Île-de-France Regional Health Agency initiated a regional project aimed at Reducing Infant and Perinatal Mortality (RéMI). This initiative was primarily focused on Seine-Saint-Denis, a district characterised by excess infant mortality (death before one year of age) and perinatal mortality (foetal deaths and deaths in the first week of life).
- What's on? - 21.10.2015
Fresh insight into the causes of infant and perinatal mortality in the Seine-Saint-Denis district
In 2012, the Île-de-France Regional Health Agency initiated a regional project aimed at Reducing Infant and Perinatal Mortality (RéMI). This initiative was primarily focused on Seine-Saint-Denis, a district characterised by excess infant mortality (death before one year of age) and perinatal mortality (foetal deaths and deaths in the first week of life). The 2 research […]
- Press releases - 20.10.2015
A first step in personalising stroke management
The team led by Didier Leys and Régis Bordet (UMR-S 1171, Lille 2 University, Inserm, Lille University Hospital) has identified a biomarker that makes it possible to predict the risk of haemorrhagic complications from thrombolytic treatment following a Cerebrovascular Accident (CVA or stroke).
- Press releases - 16.10.2015
Launch of the influenza vaccination campaign
Monday 12 October saw the start of the annual vaccination campaign, which will continue until the end of January 2016
- What's on? - 16.10.2015
Launch of the influenza vaccination campaign
Monday 12 October saw the start of the annual vaccination campaign, which will continue until the end of January 2016. Last winter recalled the potential seriousness of influenza, which severely affected the most vulnerable populations (mainly people over the age of 65). To better control the influenza epidemic, Inserm has created the Sentinelles network, an […]
- Press releases - 12.10.2015
Ovarian cancer: A promising approach for treating the most aggressive forms using targeted therapy
Thanks to work done at Institute Curie by a team led by Fatima Mechta-Grigoriou, Inserm Research Director, it is now possible to identify, among women with aggressive ovarian cancer, those who could benefit from a promising targeted therapy.
- Press releases - 09.10.2015
Inserm—a partner in World Arthritis Day: “Together Against Arthritis!”
On 12 October 2015, World Arthritis Day, a Research and Information Day, “Together against Arthritis” will be held at Espace Charenton, Paris, under the patronage of Mr François Hollande, President of France.
- Press releases - 08.10.2015
Rapid diagnosis of Ebola: the eZYSCREEN® test proves itself in the field
Announced at the end of 2014 during the final phase of research and development, the rapid diagnostic test for Ebola virus disease developed by the French Atomic Energy Commission (CEA), with support from the Inserm Jean Mérieux P4 high-level biological containment laboratory (Lyon), has been assessed in the field, including in Guinea, over a period of several months.